Nanoparticle-Mediated Delivery Market Size, Trends, Share, Growth, and Opportunity Forecast, 2024 - 2031 Global Industry Analysis By Product Type (Nanoparticle-based Drug Delivery Systems, Nanoparticle-based Imaging Agents), By Application (Oncology, Neurology, Cardiovascular Disorders, Infectious Diseases, Others), By End User (Hospitals & Clinics, Research Institutes, Pharmaceutical & Biotechnology Companies), and By Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

Chapter 1.    Executive Summary

1.1.  Global Nanoparticle-Mediated Delivery Market Size and Forecast, 2019 - 2031 (USD Million)

1.2.  Global Nanoparticle-Mediated Delivery Market Snapshot, by Segmentation

1.3.  Global Nanoparticle-Mediated Delivery Market Snapshot, by Region

1.4.  Global Nanoparticle-Mediated Delivery Market Snapshot, by Manufacturers

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Scope, Definition, and Assumptions

2.3.  Data Sources

2.3.1.    Secondary Sources

2.3.1.1.        Preliminary Data Mining

2.3.2.    Primary Sources

2.3.2.1.        Statistical Model

2.3.2.2.        Data Triangulation

2.3.2.3.        Research Objective

Chapter 3.    Market Outlook

3.1.  Introduction

3.2.  Key Trends

3.2.1.    Product Type Trends

3.2.2.    Application Trends

3.2.3.    End User Trends

3.3.  Market Dynamics

3.3.1.    Market Drivers

3.3.1.1.        Impact Analysis of Market Drivers

3.3.2.    Market Restraints

3.3.2.1.        Impact Analysis of Market Restraints

3.3.3.    Market Opportunities

3.3.3.1.        Impact Analysis of Market Opportunities

3.3.4.    Market Challenges

3.3.4.1.        Impact Analysis of Market Challenges

3.4.  Porter’s Five Forces’ Analysis

3.4.1.    Bargaining Power of Suppliers

3.4.2.    Bargaining Power of Buyers

3.4.3.    Threat of New Entrant

3.4.4.    Threat of Substitutes

3.4.5.    Competitive Rivalry

3.5.  Value Chain Analysis

3.6.  COVID-19 Impact Assessment in Nanoparticle-Mediated Delivery Market

3.6.1.    Impact Assessment on Global Nanoparticle-Mediated Delivery Market

3.6.2.    Market Trends and Opportunities in the Covid-19 Landscape

3.7.  Industry SWOT Analysis: Global Nanoparticle-Mediated Delivery Market

3.8.  PESTLE Analysis: Global Nanoparticle-Mediated Delivery Market

Chapter 4.    Competitive Landscape

4.1.  Global Nanoparticle-Mediated Delivery Market Revenue and Share by Manufacturers (2021 and 2023)

4.2.  Global Nanoparticle-Mediated Delivery Market Concentration Rate

4.2.1.    Nanoparticle-Mediated Delivery Market Share of Top 3 and Top 5 Manufacturers

4.3.    Competitive Environment, 2023

4.3.1.    Player Competition Dashboard, 2023

4.3.2.    Heat Map Analysis – Market Competition

4.3.3.    Pyramid Analysis – Tier Wise Ranking

4.4.    Strategic Framework

4.4.1.    Partnership/Collaborations/Agreement

4.4.2.    Expansion

4.4.3.    Mergers & Acquisitions

4.4.4.    New Product Development

Chapter 5.    Global Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

5.1.  Global Nanoparticle-Mediated Delivery Market Share, By Product Type, 2019 - 2031 (USD Million)

5.1.1.    Nanoparticle-based Drug Delivery Systems

5.1.1.1.        Overview

5.1.1.2.        Market Size and Projections, 2019 - 2031 (USD Million)

5.1.2.    Nanoparticle-based Imaging Agents

5.1.2.1.        Overview

5.1.2.2.        Market Size and Projections, 2019 - 2031 (USD Million)

5.2.  Market Attractiveness Analysis, by Product Type

Chapter 6.    Global Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

6.1.  Global Nanoparticle-Mediated Delivery Market Share, By Application, 2019 - 2031 (USD Million)

6.1.1.    Oncology

6.1.1.1.        Overview

6.1.1.2.        Market Size and Projections, 2019 - 2031 (USD Million)

6.1.2.    Neurology

6.1.2.1.        Overview

6.1.2.2.        Market Size and Projections, 2019 - 2031 (USD Million)

6.1.3.    Cardiovascular Disorders

6.1.3.1.        Overview

6.1.3.2.        Market Size and Projections, 2019 - 2031 (USD Million)

6.1.4.    Infectious Diseases

6.1.4.1.        Overview

6.1.4.2.        Market Size and Projections, 2019 - 2031 (USD Million)

6.1.5.    Others

6.1.5.1.        Overview

6.1.5.2.        Market Size and Projections, 2019 - 2031 (USD Million)

6.2.  Market Attractiveness Analysis, by Application

Chapter 7.    Global Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

7.1.  Global Nanoparticle-Mediated Delivery Market Share, By End User, 2019 - 2031 (USD Million)

7.1.1.    Hospitals & Clinics

7.1.1.1.        Overview

7.1.1.2.        Market Size and Projections, 2019 - 2031 (USD Million)

7.1.2.    Research Institutes

7.1.2.1.        Overview

7.1.2.2.        Market Size and Projections, 2019 - 2031 (USD Million)

7.1.3.    Pharmaceutical & Biotechnology Companies

7.1.3.1.        Overview

7.1.3.2.        Market Size and Projections, 2019 - 2031 (USD Million)

7.2.  Market Attractiveness Analysis, by End User

Chapter 8.    Global Nanoparticle-Mediated Delivery Market Overview, By Geography, 2019 - 2031 (USD Million)

8.1.  Global Nanoparticle-Mediated Delivery Market Share, By Geography, 2019 - 2031 (USD Million)

8.1.1.    Market Size and Projections, by Countries, 2019 - 2031 (USD Million)

8.1.2.    Market Share and CAGR Comparison, by Countries, 2023 and 2030 (%)

8.2.  Market Attractiveness Analysis, by Geography

Chapter 9.    North America Nanoparticle-Mediated Delivery Market Overview, By Countries, 2019 - 2031 (USD Million)

9.1.    North America Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

9.1.1.    Market size and projections, 2019 - 2031 (USD Million)

9.1.2.    North America Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

9.1.3.    North America Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

9.1.4.    North America Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

9.2.    North America Nanoparticle-Mediated Delivery Market Overview, By Countries, 2019 - 2031 (USD Million)

9.2.1.    U.S. Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

9.2.1.1.        U.S. Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

9.2.1.2.        U.S. Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

9.2.1.3.        U.S. Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

9.2.2.    Canada Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

9.2.2.1.        Canada Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

9.2.2.2.        Canada Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

9.2.2.3.        Canada Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

9.2.3.    Mexico Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

9.2.3.1.        Mexico Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

9.2.3.2.        Mexico Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

9.2.3.3.        Mexico Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

Chapter 10.Europe Nanoparticle-Mediated Delivery Market Overview, By Countries, 2019 - 2031 (USD Million)

10.1.Europe Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

10.1.1.Market size and projections, 2019 - 2031 (USD Million)

10.1.2.Europe Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

10.1.3.Europe Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

10.1.4.Europe Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

10.2.Europe Nanoparticle-Mediated Delivery Market Overview, By Countries, 2019 - 2031 (USD Million)

10.2.1.Germany Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

10.2.1.1.     Germany Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

10.2.1.2.     Germany Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

10.2.1.3.     Germany Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

10.2.2.France Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

10.2.2.1.     France Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

10.2.2.2.     France Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

10.2.2.3.     France Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

10.2.3.UK Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

10.2.3.1.     UK Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

10.2.3.2.     UK Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

10.2.3.3.     UK Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

10.2.4.Italy Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

10.2.4.1.     Italy Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

10.2.4.2.     Italy Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

10.2.4.3.     Italy Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

10.2.5.Russia Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

10.2.5.1.     Russia Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

10.2.5.2.     Russia Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

10.2.5.3.     Russia Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

10.2.6.Rest of Europe Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

10.2.6.1.     Rest of Europe Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

10.2.6.2.     Rest of Europe Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

10.2.6.3.     Rest of Europe Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

Chapter 11.Asia Pacific Nanoparticle-Mediated Delivery Market Overview, By Countries, 2019 - 2031 (USD Million)

11.1.Asia Pacific Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

11.1.1.Market size and projections, 2019 - 2031 (USD Million)

11.1.2.Asia Pacific Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

11.1.3.Asia Pacific Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

11.1.4.Asia Pacific Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

11.2.Asia Pacific Nanoparticle-Mediated Delivery Market Overview, By Countries, 2019 - 2031 (USD Million)

11.2.1.India Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

11.2.1.1.     India Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

11.2.1.2.     India Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

11.2.1.3.     India Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

11.2.2.China Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

11.2.2.1.     China Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

11.2.2.2.     China Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

11.2.2.3.     China Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

11.2.3.Japan Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

11.2.3.1.     Japan Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

11.2.3.2.     Japan Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

11.2.3.3.     Japan Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

11.2.4.South Korea Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

11.2.4.1.     South Korea Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

11.2.4.2.     South Korea Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

11.2.4.3.     South Korea Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

11.2.5.Australia Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

11.2.5.1.     Australia Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

11.2.5.2.     Australia Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

11.2.5.3.     Australia Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

11.2.6.Rest of Asia Pacific Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

11.2.6.1.     Rest of Asia Pacific Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

11.2.6.2.     Rest of Asia Pacific Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

11.2.6.3.     Rest of Asia Pacific Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

Chapter 12.South America Nanoparticle-Mediated Delivery Market Overview, By Countries, 2019 - 2031 (USD Million)

12.1.South America Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

12.1.1.Market size and projections, 2019 - 2031 (USD Million)

12.1.2.South America Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

12.1.3.South America Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

12.1.4.South America Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

12.2.South America Nanoparticle-Mediated Delivery Market Overview, By Countries, 2019 - 2031 (USD Million)

12.2.1.Brazil Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

12.2.1.1.     Brazil Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

12.2.1.2.     Brazil Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

12.2.1.3.     Brazil Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

12.2.2.Argentina Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

12.2.2.1.     Argentina Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

12.2.2.2.     Argentina Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

12.2.2.3.     Argentina Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

12.2.3.Rest of South America Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

12.2.3.1.     Rest of South America Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

12.2.3.2.     Rest of South America Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

12.2.3.3.     Rest of South America Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

Chapter 13.Middle East & Africa Nanoparticle-Mediated Delivery Market Overview, By Countries, 2019 - 2031 (USD Million)

13.1.Middle East & Africa Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

13.1.1.Market size and projections, 2019 - 2031 (USD Million)

13.1.2.Middle East & Africa Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

13.1.3.Middle East & Africa Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

13.1.4.Middle East & Africa Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

13.2.Middle East & Africa Nanoparticle-Mediated Delivery Market Overview, By Countries, 2019 - 2031 (USD Million)

13.2.1.GCC Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

13.2.1.1.     GCC Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

13.2.1.2.     GCC Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

13.2.1.3.     GCC Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

13.2.2.South Africa Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

13.2.2.1.     South Africa Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

13.2.2.2.     South Africa Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

13.2.2.3.     South Africa Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

13.2.3.Rest of Middle East & Africa Nanoparticle-Mediated Delivery Market Overview, 2019 - 2031 (USD Million)

13.2.3.1.     Rest of Middle East & Africa Nanoparticle-Mediated Delivery Market Overview, By Product Type, 2019 - 2031 (USD Million)

13.2.3.2.     Rest of Middle East & Africa Nanoparticle-Mediated Delivery Market Overview, By Application, 2019 - 2031 (USD Million)

13.2.3.3.     Rest of Middle East & Africa Nanoparticle-Mediated Delivery Market Overview, By End User, 2019 - 2031 (USD Million)

Chapter 14.Key Vendor Analysis

14.1.Pfizer Inc.*

14.1.1.     Business Overview

14.1.2.     Product Benchmarking

14.1.3.     Financial Data

14.1.4.     SWOT Analysis

14.1.5.     Strategic Overview

14.1.6.     Key Developments

*Similar sub-pointers will be included for rest of the companies listed below

14.2.   Merck & Co., Inc.

14.3.   Novartis AG

14.4.   Johnson & Johnson Services, Inc.

14.5.   Roche Holding AG

14.6.   Sanofi S.A.

14.7.   Amgen Inc.

14.8.   AbbVie Inc.

14.9.   Gilead Sciences, Inc.

14.10.AstraZeneca PLC

14.11.Bristol Myers Squibb Company

14.12.Eli Lilly and Company

14.13.GlaxoSmithKline PLC

14.14.Takeda Pharmaceutical Company Limited

14.15.Biogen Inc.

Chapter 15.Key Conclusions & Analyst Recommendations

Disclaimer